Omalizumab for severe chronic spontaneous urticaria: Real-life experiences of 280 patients

Zahava Vadasz; Yuval Tal; Menachem Rotem; Vered Shichter-Confino; Keren Mahlab-Guri; Yael Graif; Aharon Kessel; Nancy Agmon-Levin; Ramit Maoz-Segal; Shmuel Kivity; Shira Benor; Idit Lachover-Roth; Yuri Zeldin; Migel Stein; Ori Toker; Gamal Hassoun; Shira Bezalel-Rosenberg; Elias Toubi; Ilan Asher; Zev Sthoeger

doi:10.1016/j.jaip.2017.08.035

Omalizumab for severe chronic spontaneous urticaria: Real-life experiences of 280 patients

Zahava Vadasz^*, Yuval Tal, Menachem Rotem, Vered Shichter-Confino, Keren Mahlab-Guri, Yael Graif, Aharon Kessel, Nancy Agmon-Levin, Ramit Maoz-Segal, Shmuel Kivity, Shira Benor, Idit Lachover-Roth, Yuri Zeldin, Migel Stein, Ori Toker, Gamal Hassoun, Shira Bezalel-Rosenberg, Elias Toubi, Ilan Asher, Zev Sthoeger

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

49 Scopus citations

Original language	English
Pages (from-to)	1743-1745
Number of pages	3
Journal	Journal of Allergy and Clinical Immunology: In Practice
Volume	5
Issue number	6
DOIs	https://doi.org/10.1016/j.jaip.2017.08.035
State	Published - Nov 2017
Externally published	Yes

Access to Document

10.1016/j.jaip.2017.08.035

Cite this

Vadasz, Z., Tal, Y., Rotem, M., Shichter-Confino, V., Mahlab-Guri, K., Graif, Y., Kessel, A., Agmon-Levin, N., Maoz-Segal, R., Kivity, S., Benor, S., Lachover-Roth, I., Zeldin, Y., Stein, M., Toker, O., Hassoun, G., Bezalel-Rosenberg, S., Toubi, E., Asher, I., & Sthoeger, Z. (2017). Omalizumab for severe chronic spontaneous urticaria: Real-life experiences of 280 patients. Journal of Allergy and Clinical Immunology: In Practice, 5(6), 1743-1745. https://doi.org/10.1016/j.jaip.2017.08.035

@article{16105565c68f46e2826a9625045bf605,

title = "Omalizumab for severe chronic spontaneous urticaria: Real-life experiences of 280 patients",

author = "Zahava Vadasz and Yuval Tal and Menachem Rotem and Vered Shichter-Confino and Keren Mahlab-Guri and Yael Graif and Aharon Kessel and Nancy Agmon-Levin and Ramit Maoz-Segal and Shmuel Kivity and Shira Benor and Idit Lachover-Roth and Yuri Zeldin and Migel Stein and Ori Toker and Gamal Hassoun and Shira Bezalel-Rosenberg and Elias Toubi and Ilan Asher and Zev Sthoeger",

year = "2017",

month = nov,

doi = "10.1016/j.jaip.2017.08.035",

language = "אנגלית",

volume = "5",

pages = "1743--1745",

journal = "Journal of Allergy and Clinical Immunology: In Practice",

issn = "2213-2198",

publisher = "American Academy of Allergy, Asthma and Immunology",

number = "6",

}

Vadasz, Z, Tal, Y, Rotem, M, Shichter-Confino, V, Mahlab-Guri, K, Graif, Y, Kessel, A, Agmon-Levin, N, Maoz-Segal, R, Kivity, S, Benor, S, Lachover-Roth, I, Zeldin, Y, Stein, M, Toker, O, Hassoun, G, Bezalel-Rosenberg, S, Toubi, E, Asher, I & Sthoeger, Z 2017, 'Omalizumab for severe chronic spontaneous urticaria: Real-life experiences of 280 patients', Journal of Allergy and Clinical Immunology: In Practice, vol. 5, no. 6, pp. 1743-1745. https://doi.org/10.1016/j.jaip.2017.08.035

TY - JOUR

T1 - Omalizumab for severe chronic spontaneous urticaria

T2 - Real-life experiences of 280 patients

AU - Vadasz, Zahava

AU - Tal, Yuval

AU - Rotem, Menachem

AU - Shichter-Confino, Vered

AU - Mahlab-Guri, Keren

AU - Graif, Yael

AU - Kessel, Aharon

AU - Agmon-Levin, Nancy

AU - Maoz-Segal, Ramit

AU - Kivity, Shmuel

AU - Benor, Shira

AU - Lachover-Roth, Idit

AU - Zeldin, Yuri

AU - Stein, Migel

AU - Toker, Ori

AU - Hassoun, Gamal

AU - Bezalel-Rosenberg, Shira

AU - Toubi, Elias

AU - Asher, Ilan

AU - Sthoeger, Zev

PY - 2017/11

Y1 - 2017/11

UR - http://www.scopus.com/inward/record.url?scp=85030476912&partnerID=8YFLogxK

U2 - 10.1016/j.jaip.2017.08.035

DO - 10.1016/j.jaip.2017.08.035

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???

C2 - 28988786

AN - SCOPUS:85030476912

SN - 2213-2198

VL - 5

SP - 1743

EP - 1745

JO - Journal of Allergy and Clinical Immunology: In Practice

JF - Journal of Allergy and Clinical Immunology: In Practice

IS - 6

ER -

Omalizumab for severe chronic spontaneous urticaria: Real-life experiences of 280 patients

Access to Document

Other files and links

Cite this